Genetic Analyses of the Chimeric CYP11B1 / CYP11B2 Gene in a Korean Family with Glucocorticoid-Remediable Aldosteronism

Glucocorticoid-remediable aldosteronism (GRA) is an autosomal-dominant inheritable form of hyperaldosteronism with early onset hypertension. GRA is caused by unequal crossing-over of the steroid 11 beta-hydroxylase (CYP11B1) and aldosterone synthase (CYP11B2) genes. As a result of chimeric gene dupl...

Full description

Saved in:
Bibliographic Details
Published inJournal of Korean medical science Vol. 25; no. 9; pp. 1379 - 1383
Main Authors Lee, Ihn Suk, Kim, Seul Young, Jang, Hye Won, Kim, Min Kyeong, Lee, Ju Hee, Lee, Yun Hyeong, Jo, Young Suk
Format Journal Article
LanguageEnglish
Published Korea (South) The Korean Academy of Medical Sciences 01.09.2010
대한의학회
Subjects
Online AccessGet full text
ISSN1011-8934
1598-6357
1598-6357
DOI10.3346/jkms.2010.25.9.1379

Cover

Loading…
Abstract Glucocorticoid-remediable aldosteronism (GRA) is an autosomal-dominant inheritable form of hyperaldosteronism with early onset hypertension. GRA is caused by unequal crossing-over of the steroid 11 beta-hydroxylase (CYP11B1) and aldosterone synthase (CYP11B2) genes. As a result of chimeric gene duplication, aldosterone is ectopically synthesized in the adrenal zona fasciculata under the control of adrenocorticotropin. Here, we describe three cases of GRA in a Korean family. The proband-a 21-yr-old female-was incidentally found to have high blood pressure (170/108 mmHg). Her 46-yr-old father had been treated twice for cerebral hemorrhage at the ages of 29 and 39 yr. Her 15-yr-old brother had a 2-yr history of hypertension; however, he was never treated. Their laboratory test results showed normokalemia, hyporeninemia, hyperaldosteronism, and a high plasma aldosterone concentration-to-plasma renin activity ratio. Normal saline loading failed to suppress aldosterone secretion. However, dexamethasone administration effectively suppressed their plasma aldosterone concentrations. Following genetic analyses with PCR and direct sequencing to document the chimeric gene and crossover site, respectively, we identified CYP11B1/CYP11B2 and determined the breakpoint of unequal crossover to be located between intron 2 of CYP11B1 and exon 3 of CYP11B2.
AbstractList Glucocorticoid-remediable aldosteronism (GRA) is an autosomal-dominant inheritable form of hyperaldosteronism with early onset hypertension. GRA is caused by unequal crossing-over of the steroid 11 beta-hydroxylase (CYP11B1) and aldosterone synthase (CYP11B2) genes. As a result of chimeric gene duplication, aldosterone is ectopically synthesized in the adrenal zona fasciculata under the control of adrenocorticotropin. Here, we describe three cases of GRA in a Korean family. The proband-a 21-yr-old female-was incidentally found to have high blood pressure (170/108 mmHg). Her 46-yr-old father had been treated twice for cerebral hemorrhage at the ages of 29 and 39 yr. Her 15-yr-old brother had a 2-yr history of hypertension; however, he was never treated. Their laboratory test results showed normokalemia, hyporeninemia, hyperaldosteronism, and a high plasma aldosterone concentration-to-plasma renin activity ratio. Normal saline loading failed to suppress aldosterone secretion. However, dexamethasone administration effectively suppressed their plasma aldosterone concentrations. Following genetic analyses with PCR and direct sequencing to document the chimeric gene and crossover site, respectively, we identified CYP11B1/CYP11B2 and determined the breakpoint of unequal crossover to be located between intron 2 of CYP11B1 and exon 3 of CYP11B2.Glucocorticoid-remediable aldosteronism (GRA) is an autosomal-dominant inheritable form of hyperaldosteronism with early onset hypertension. GRA is caused by unequal crossing-over of the steroid 11 beta-hydroxylase (CYP11B1) and aldosterone synthase (CYP11B2) genes. As a result of chimeric gene duplication, aldosterone is ectopically synthesized in the adrenal zona fasciculata under the control of adrenocorticotropin. Here, we describe three cases of GRA in a Korean family. The proband-a 21-yr-old female-was incidentally found to have high blood pressure (170/108 mmHg). Her 46-yr-old father had been treated twice for cerebral hemorrhage at the ages of 29 and 39 yr. Her 15-yr-old brother had a 2-yr history of hypertension; however, he was never treated. Their laboratory test results showed normokalemia, hyporeninemia, hyperaldosteronism, and a high plasma aldosterone concentration-to-plasma renin activity ratio. Normal saline loading failed to suppress aldosterone secretion. However, dexamethasone administration effectively suppressed their plasma aldosterone concentrations. Following genetic analyses with PCR and direct sequencing to document the chimeric gene and crossover site, respectively, we identified CYP11B1/CYP11B2 and determined the breakpoint of unequal crossover to be located between intron 2 of CYP11B1 and exon 3 of CYP11B2.
Glucocorticoid-remediable aldosteronism (GRA) is an autosomal-dominant inheritable form of hyperaldosteronism with early onset hypertension. GRA is caused by unequal crossing-over of the steroid 11 beta-hydroxylase (CYP11B1) and aldosterone synthase (CYP11B2) genes. As a result of chimeric gene duplication, aldosterone is ectopically synthesized in the adrenal zona fasciculata under the control of adrenocorticotropin. Here, we describe three cases of GRA in a Korean family. The proband-a 21-yr-old female-was incidentally found to have high blood pressure (170/108 mmHg). Her 46-yr-old father had been treated twice for cerebral hemorrhage at the ages of 29 and 39 yr. Her 15-yr-old brother had a 2-yr history of hypertension; however, he was never treated. Their laboratory test results showed normokalemia, hyporeninemia, hyperaldosteronism, and a high plasma aldosterone concentration-to-plasma renin activity ratio. Normal saline loading failed to suppress aldosterone secretion. However, dexamethasone administration effectively suppressed their plasma aldosterone concentrations. Following genetic analyses with PCR and direct sequencing to document the chimeric gene and crossover site, respectively, we identified CYP11B1/CYP11B2 and determined the breakpoint of unequal crossover to be located between intron 2 of CYP11B1 and exon 3 of CYP11B2.
Glucocorticoid-remediable aldosteronism (GRA) is an autosomal-dominant inheritable form of hyperaldosteronism with early onset hypertension. GRA is caused by unequal crossing-over of the steroid 11β-hydroxylase ( CYP11B1 ) and aldosterone synthase ( CYP11B2 ) genes. As a result of chimeric gene duplication, aldosterone is ectopically synthesized in the adrenal zona fasciculata under the control of adrenocorticotropin. Here, we describe three cases of GRA in a Korean family. The proband-a 21-yr-old female-was incidentally found to have high blood pressure (170/108 mmHg). Her 46-yr-old father had been treated twice for cerebral hemorrhage at the ages of 29 and 39 yr. Her 15-yr-old brother had a 2-yr history of hypertension; however, he was never treated. Their laboratory test results showed normokalemia, hyporeninemia, hyperaldosteronism, and a high plasma aldosterone concentration-to-plasma renin activity ratio. Normal saline loading failed to suppress aldosterone secretion. However, dexamethasone administration effectively suppressed their plasma aldosterone concentrations. Following genetic analyses with PCR and direct sequencing to document the chimeric gene and crossover site, respectively, we identified CYP11B1 / CYP11B2 and determined the breakpoint of unequal crossover to be located between intron 2 of CYP11B1 and exon 3 of CYP11B2 .
Glucocorticoid-remediable aldosteronism (GRA) is an autosomal-dominant inheritable form of hyperaldosteronism with early onset hypertension. GRA is caused by unequal crossing-over of the steroid 11β-hydroxylase (CYP11B1) and aldosterone synthase (CYP11B2)genes. As a result of chimeric gene duplication, aldosterone is ectopically synthesized in the adrenal zona fasciculata under the control of adrenocorticotropin. Here, we describe three cases of GRA in a Korean family. The proband-a 21-yr-old female-was incidentally found to have high blood pressure (170/108 mmHg). Her 46-yr-old father had been treated twice for cerebral hemorrhage at the ages of 29 and 39 yr. Her 15-yr-old brother had a 2-yr history of hypertension; however, he was never treated. Their laboratory test results showed normokalemia, hyporeninemia, hyperaldosteronism, and a high plasma aldosterone concentration-to-plasma renin activity ratio. Normal saline loading failed to suppress aldosterone secretion. However, dexamethasone administration effectively suppressed their plasma aldosterone concentrations. Following genetic analyses with PCR and direct sequencing to document the chimeric gene and crossover site, respectively, we identified CYP11B1/CYP11B2 and determined the breakpoint of unequal crossover to be located between intron 2 of CYP11B1 and exon 3 of CYP11B2. KCI Citation Count: 2
Author Jo, Young Suk
Kim, Seul Young
Lee, Ju Hee
Lee, Yun Hyeong
Jang, Hye Won
Lee, Ihn Suk
Kim, Min Kyeong
AuthorAffiliation 2 Division of Endocrinology, Department of Internal Medicine, Chungnam National University School of Medicine, Daejeon, Korea
1 Division of Endocrinology, Department of Internal Medicine, Incheon Medical Center, Incheon, Korea
AuthorAffiliation_xml – name: 1 Division of Endocrinology, Department of Internal Medicine, Incheon Medical Center, Incheon, Korea
– name: 2 Division of Endocrinology, Department of Internal Medicine, Chungnam National University School of Medicine, Daejeon, Korea
Author_xml – sequence: 1
  givenname: Ihn Suk
  surname: Lee
  fullname: Lee, Ihn Suk
  organization: Division of Endocrinology, Department of Internal Medicine, Incheon Medical Center, Incheon, Korea
– sequence: 2
  givenname: Seul Young
  surname: Kim
  fullname: Kim, Seul Young
  organization: Division of Endocrinology, Department of Internal Medicine, Chungnam National University School of Medicine, Daejeon, Korea
– sequence: 3
  givenname: Hye Won
  surname: Jang
  fullname: Jang, Hye Won
  organization: Division of Endocrinology, Department of Internal Medicine, Chungnam National University School of Medicine, Daejeon, Korea
– sequence: 4
  givenname: Min Kyeong
  surname: Kim
  fullname: Kim, Min Kyeong
  organization: Division of Endocrinology, Department of Internal Medicine, Chungnam National University School of Medicine, Daejeon, Korea
– sequence: 5
  givenname: Ju Hee
  surname: Lee
  fullname: Lee, Ju Hee
  organization: Division of Endocrinology, Department of Internal Medicine, Chungnam National University School of Medicine, Daejeon, Korea
– sequence: 6
  givenname: Yun Hyeong
  surname: Lee
  fullname: Lee, Yun Hyeong
  organization: Division of Endocrinology, Department of Internal Medicine, Chungnam National University School of Medicine, Daejeon, Korea
– sequence: 7
  givenname: Young Suk
  surname: Jo
  fullname: Jo, Young Suk
  organization: Division of Endocrinology, Department of Internal Medicine, Chungnam National University School of Medicine, Daejeon, Korea
BackLink https://www.ncbi.nlm.nih.gov/pubmed/20808686$$D View this record in MEDLINE/PubMed
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001469820$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNp9kUtvEzEUhS1URB_wC5CQd7CZ1K-ZjDdIIaKhohKoKgtWlse-Q9x47NaeUOXf42lCBSxY-Vr3O-de-5yioxADIPSakhnnojm_3Qx5xki5snomZ5TP5TN0QmvZVg2v50elJpRWreTiGJ3mfEsIq2vGX6BjRlrSNm1zgh5WEGB0Bi-C9rsMGccej2vAy7UbIJXG8vtXSj9QfH6oGJ4k2AWs8eeYQAd8oQfnd_jBjWu88lsTTUzFMzpbXcMA1unOA154G_MIKQaXh5foea99hleH8wx9u_h4s_xUXX1ZXS4XV5Xhko1VJ5q50La1PZSHNZq3neSko1TarrZNo60kwtBeCAG90VxaZhmQjsmu5RI0P0Pv9r4h9WpjnIraPZ4_otoktbi-uVT1XJCWF_T9Hr3bdmVpA2FM2qu75Aaddo_CvzvBrYvNT8UkK3_fFoO3B4MU77eQRzW4bMB7HSBus5rXXErZEFHIN3-OeprxO5cC8D1gUsw5Qf-EUKKm9NWUvprSV6xWUk3pF5X8R2XcqEcXp32d_6_2F0DDtiY
CitedBy_id crossref_primary_10_3389_fped_2020_588911
crossref_primary_10_3803_EnM_2012_27_4_329
crossref_primary_10_1097_MED_0b013e3283469444
crossref_primary_10_1210_clinem_dgae127
crossref_primary_10_1210_clinem_dgae523
crossref_primary_10_1093_ajh_hpaf005
crossref_primary_10_1097_MED_0b013e3283473d73
crossref_primary_10_1155_2018_8647026
crossref_primary_10_3389_fped_2019_00263
Cites_doi 10.1161/01.HYP.38.3.688
10.1067/mpd.2001.112648
10.1006/bbrc.1995.1225
10.1590/S0004-27302004000500014
10.1038/355262a0
10.1016/S0960-0760(01)00097-8
10.1016/0039-128X(94)00010-A
10.1210/jcem.85.9.6834
10.1046/j.1440-1681.2001.03574.x
10.1038/sj.jhh.1001821
10.1210/jcem.84.12.6256
10.1038/sj.jhh.1001152
ContentType Journal Article
Copyright 2010 The Korean Academy of Medical Sciences. 2010
Copyright_xml – notice: 2010 The Korean Academy of Medical Sciences. 2010
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ACYCR
DOI 10.3346/jkms.2010.25.9.1379
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
Korean Citation Index
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE


Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1598-6357
EndPage 1383
ExternalDocumentID oai_kci_go_kr_ARTI_574083
PMC2923798
20808686
10_3346_jkms_2010_25_9_1379
Genre Journal Article
Case Reports
GeographicLocations Republic of Korea
GeographicLocations_xml – name: Republic of Korea
GroupedDBID ---
29K
2WC
3O-
5-W
53G
5GY
8JR
8XY
9ZL
AAYXX
ADBBV
ADRAZ
AENEX
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
CITATION
CS3
D-I
DIK
DU5
E3Z
EBS
EF.
EJD
F5P
FRP
GROUPED_DOAJ
GX1
HYE
KQ8
M48
O5R
O5S
OK1
OVT
PGMZT
RNS
RPM
TR2
W2D
XSB
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ACYCR
ID FETCH-LOGICAL-c392t-b4674ad8dfe1596a38b930b119db5d66ad904c1f444efca39d2d2e0b29b839ea3
IEDL.DBID M48
ISSN 1011-8934
1598-6357
IngestDate Sun Mar 09 07:53:53 EDT 2025
Thu Aug 21 14:06:20 EDT 2025
Fri Jul 11 02:57:01 EDT 2025
Thu Apr 03 07:00:13 EDT 2025
Tue Jul 01 01:44:44 EDT 2025
Thu Apr 24 23:01:26 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 9
Keywords Hyperaldosteronism
Aldosterone Synthase
Steroid 11-beta-Hydroxylase
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c392t-b4674ad8dfe1596a38b930b119db5d66ad904c1f444efca39d2d2e0b29b839ea3
Notes ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
Ihn Suk Lee and Seul Young Kim contributed equally to the work.
http://kmbase.medric.or.kr/Main.aspx?d=KMBASE&m=VIEW&i=0191120100250091379
G704-000345.2010.25.9.021
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.3346/jkms.2010.25.9.1379
PMID 20808686
PQID 753999604
PQPubID 23479
PageCount 5
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_574083
pubmedcentral_primary_oai_pubmedcentral_nih_gov_2923798
proquest_miscellaneous_753999604
pubmed_primary_20808686
crossref_primary_10_3346_jkms_2010_25_9_1379
crossref_citationtrail_10_3346_jkms_2010_25_9_1379
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2010-09-01
PublicationDateYYYYMMDD 2010-09-01
PublicationDate_xml – month: 09
  year: 2010
  text: 2010-09-01
  day: 01
PublicationDecade 2010
PublicationPlace Korea (South)
PublicationPlace_xml – name: Korea (South)
PublicationTitle Journal of Korean medical science
PublicationTitleAlternate J Korean Med Sci
PublicationYear 2010
Publisher The Korean Academy of Medical Sciences
대한의학회
Publisher_xml – name: The Korean Academy of Medical Sciences
– name: 대한의학회
References Litchfield (10.3346/jkms.2010.25.9.1379_ref10) 1997; 82
Stowasser (10.3346/jkms.2010.25.9.1379_ref13) 2000; 85
Jonsson (10.3346/jkms.2010.25.9.1379_ref5) 1995; 207
Lifton (10.3346/jkms.2010.25.9.1379_ref2) 1992; 355
Mosso (10.3346/jkms.2010.25.9.1379_ref3) 2001; 38
Pizzolo (10.3346/jkms.2010.25.9.1379_ref7) 2005; 19
Gates (10.3346/jkms.2010.25.9.1379_ref9) 2001; 15
Stowasser (10.3346/jkms.2010.25.9.1379_ref12) 2001; 28
Dluhy (10.3346/jkms.2010.25.9.1379_ref17) 2001; 138
Dluhy (10.3346/jkms.2010.25.9.1379_ref14) 1995; 60
Stowasser (10.3346/jkms.2010.25.9.1379_ref15) 2000; 85
McMahon (10.3346/jkms.2010.25.9.1379_ref8) 2004; 48
Stowasser (10.3346/jkms.2010.25.9.1379_ref11) 2001; 78
Dluhy (10.3346/jkms.2010.25.9.1379_ref16) 1999; 84
Fardella (10.3346/jkms.2010.25.9.1379_ref4) 2000; 85
Loh (10.3346/jkms.2010.25.9.1379_ref6) 2000; 85
Sutherland (10.3346/jkms.2010.25.9.1379_ref1) 1966; 95
15660117 - J Hum Hypertens. 2005 Apr;19(4):325-7
11317201 - J Hum Hypertens. 2001 Mar;15(3):173-6
4288576 - Can Med Assoc J. 1966 Nov 26;95(22):1109-19
15761539 - Arq Bras Endocrinol Metabol. 2004 Oct;48(5):682-6
7864844 - Biochem Biophys Res Commun. 1995 Feb 15;207(2):565-71
1731223 - Nature. 1992 Jan 16;355(6357):262-5
11343049 - J Pediatr. 2001 May;138(5):715-20
11903322 - Clin Exp Pharmacol Physiol. 2001 Dec;28(12):1087-90
10999827 - J Clin Endocrinol Metab. 2000 Sep;85(9):3313-8
9360508 - J Clin Endocrinol Metab. 1997 Nov;82(11):3570-3
11566957 - Hypertension. 2001 Sep;38(3 Pt 2):688-91
11595502 - J Steroid Biochem Mol Biol. 2001 Sep;78(3):215-29
7792815 - Steroids. 1995 Jan;60(1):48-51
10843166 - J Clin Endocrinol Metab. 2000 May;85(5):1863-7
10946893 - J Clin Endocrinol Metab. 2000 Aug;85(8):2854-9
10599685 - J Clin Endocrinol Metab. 1999 Dec;84(12):4341-4
10852446 - J Clin Endocrinol Metab. 2000 Jun;85(6):2160-6
References_xml – volume: 38
  start-page: 688
  year: 2001
  ident: 10.3346/jkms.2010.25.9.1379_ref3
  publication-title: Hypertension
  doi: 10.1161/01.HYP.38.3.688
– volume: 138
  start-page: 715
  year: 2001
  ident: 10.3346/jkms.2010.25.9.1379_ref17
  publication-title: J Pediatr
  doi: 10.1067/mpd.2001.112648
– volume: 85
  start-page: 1863
  year: 2000
  ident: 10.3346/jkms.2010.25.9.1379_ref4
  publication-title: J Clin Endocrinol Metab
– volume: 207
  start-page: 565
  year: 1995
  ident: 10.3346/jkms.2010.25.9.1379_ref5
  publication-title: Biochem Biophys Res Commun
  doi: 10.1006/bbrc.1995.1225
– volume: 48
  start-page: 682
  year: 2004
  ident: 10.3346/jkms.2010.25.9.1379_ref8
  publication-title: Arq Bras Endocrinol Metabol
  doi: 10.1590/S0004-27302004000500014
– volume: 355
  start-page: 262
  year: 1992
  ident: 10.3346/jkms.2010.25.9.1379_ref2
  publication-title: Nature
  doi: 10.1038/355262a0
– volume: 82
  start-page: 3570
  year: 1997
  ident: 10.3346/jkms.2010.25.9.1379_ref10
  publication-title: J Clin Endocrinol Metab
– volume: 78
  start-page: 215
  year: 2001
  ident: 10.3346/jkms.2010.25.9.1379_ref11
  publication-title: J Steroid Biochem Mol Biol
  doi: 10.1016/S0960-0760(01)00097-8
– volume: 60
  start-page: 48
  year: 1995
  ident: 10.3346/jkms.2010.25.9.1379_ref14
  publication-title: Steroids
  doi: 10.1016/0039-128X(94)00010-A
– volume: 85
  start-page: 3313
  year: 2000
  ident: 10.3346/jkms.2010.25.9.1379_ref15
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jcem.85.9.6834
– volume: 28
  start-page: 1087
  year: 2001
  ident: 10.3346/jkms.2010.25.9.1379_ref12
  publication-title: Clin Exp Pharmacol Physiol
  doi: 10.1046/j.1440-1681.2001.03574.x
– volume: 85
  start-page: 2160
  year: 2000
  ident: 10.3346/jkms.2010.25.9.1379_ref13
  publication-title: J Clin Endocrinol Metab
– volume: 95
  start-page: 1109
  year: 1966
  ident: 10.3346/jkms.2010.25.9.1379_ref1
  publication-title: Can Med Assoc J
– volume: 19
  start-page: 325
  year: 2005
  ident: 10.3346/jkms.2010.25.9.1379_ref7
  publication-title: J Hum Hypertens
  doi: 10.1038/sj.jhh.1001821
– volume: 84
  start-page: 4341
  year: 1999
  ident: 10.3346/jkms.2010.25.9.1379_ref16
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jcem.84.12.6256
– volume: 85
  start-page: 2854
  year: 2000
  ident: 10.3346/jkms.2010.25.9.1379_ref6
  publication-title: J Clin Endocrinol Metab
– volume: 15
  start-page: 173
  year: 2001
  ident: 10.3346/jkms.2010.25.9.1379_ref9
  publication-title: J Hum Hypertens
  doi: 10.1038/sj.jhh.1001152
– reference: 10946893 - J Clin Endocrinol Metab. 2000 Aug;85(8):2854-9
– reference: 4288576 - Can Med Assoc J. 1966 Nov 26;95(22):1109-19
– reference: 11317201 - J Hum Hypertens. 2001 Mar;15(3):173-6
– reference: 10999827 - J Clin Endocrinol Metab. 2000 Sep;85(9):3313-8
– reference: 7864844 - Biochem Biophys Res Commun. 1995 Feb 15;207(2):565-71
– reference: 15761539 - Arq Bras Endocrinol Metabol. 2004 Oct;48(5):682-6
– reference: 11566957 - Hypertension. 2001 Sep;38(3 Pt 2):688-91
– reference: 10852446 - J Clin Endocrinol Metab. 2000 Jun;85(6):2160-6
– reference: 7792815 - Steroids. 1995 Jan;60(1):48-51
– reference: 9360508 - J Clin Endocrinol Metab. 1997 Nov;82(11):3570-3
– reference: 11595502 - J Steroid Biochem Mol Biol. 2001 Sep;78(3):215-29
– reference: 1731223 - Nature. 1992 Jan 16;355(6357):262-5
– reference: 10599685 - J Clin Endocrinol Metab. 1999 Dec;84(12):4341-4
– reference: 11343049 - J Pediatr. 2001 May;138(5):715-20
– reference: 15660117 - J Hum Hypertens. 2005 Apr;19(4):325-7
– reference: 10843166 - J Clin Endocrinol Metab. 2000 May;85(5):1863-7
– reference: 11903322 - Clin Exp Pharmacol Physiol. 2001 Dec;28(12):1087-90
SSID ssj0025523
Score 1.9324646
Snippet Glucocorticoid-remediable aldosteronism (GRA) is an autosomal-dominant inheritable form of hyperaldosteronism with early onset hypertension. GRA is caused by...
SourceID nrf
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 1379
SubjectTerms Adolescent
Aldosterone - blood
Asian Continental Ancestry Group - genetics
Case Report
Cytochrome P-450 CYP11B2 - genetics
Dexamethasone - therapeutic use
Family
Female
Glucocorticoids - therapeutic use
Humans
Hyperaldosteronism - diagnosis
Hyperaldosteronism - drug therapy
Hyperaldosteronism - genetics
Hypertension - etiology
Magnetic Resonance Angiography
Male
Middle Aged
Renin - blood
Renin - metabolism
Republic of Korea
Sequence Analysis, DNA
Steroid 11-beta-Hydroxylase - genetics
Young Adult
의학일반
Title Genetic Analyses of the Chimeric CYP11B1 / CYP11B2 Gene in a Korean Family with Glucocorticoid-Remediable Aldosteronism
URI https://www.ncbi.nlm.nih.gov/pubmed/20808686
https://www.proquest.com/docview/753999604
https://pubmed.ncbi.nlm.nih.gov/PMC2923798
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001469820
Volume 25
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Journal of Korean Medical Science, 2010, 25(9), 142, pp.1379-1383
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELbaIiEuiDfhsTISR7IkfiTxASGoqFqqRRxYqZwsO7ZptNsENrsS_Htm4uyqRS0nH_ySPGP5m4e_IeS1QFayUsFNUyKkQsYkAJNiBMvW3mVhYGKafSmO5-LzmTzbI9uqqOMB9teadlhPar5aTn__-vMeLvw7tDg5RigXF31M0mJyqqY5L9U-uQVPU4HW2EzswgoAnxmP1EM3TURyYABRVYGfqy-9VPvtKlwHQv_Npbz0OB3dI3dHVEk_RDW4T_Z8-4Dcno1x84dkg-zS0EfNwEHie9oFCtCP1ufNELKhh9-_5vnH_G1sGQW98rRpqaGnHeDKlkZPCEW_LR3y3MFshRW7xqXoYkQf7tJTs3T4awQJd_uLR2R-9Onb4XE6FlxIa4BJ69Ri6RHjKhc8oJzC8Moqntk8V85KVxTGqUzUeRBC-FAbrhxzzGeWKQs4yxv-mBy0XeufEiqdlKXx3MtgBcvrymeZ82WAK89M4CIhbHu4uh7ZyLEoxlKDVYLC0SgcjcLRTGqlUTgJebOb9DOScfx_-CuQml7UjUYSbWx_dHqx0mAqnGhZCoCfCaFbmWq4WBgtMa3vNr0ukbMXqWsS8iSKeLfnVkMSUl4R_m4Abne1p23OB-5uBoC6VNWzG9d8Tu7EBAVMY3tBDtarjX8JuGdtJ4D4T04ng9dgMuj1X2dDAQM
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Genetic+analyses+of+the+chimeric+CYP11B1%2FCYP11B2+gene+in+a+Korean+family+with+glucocorticoid-remediable+aldosteronism&rft.jtitle=Journal+of+Korean+medical+science&rft.au=Lee%2C+Ihn+Suk&rft.au=Kim%2C+Seul+Young&rft.au=Jang%2C+Hye+Won&rft.au=Kim%2C+Min+Kyeong&rft.date=2010-09-01&rft.eissn=1598-6357&rft.volume=25&rft.issue=9&rft.spage=1379&rft_id=info:doi/10.3346%2Fjkms.2010.25.9.1379&rft_id=info%3Apmid%2F20808686&rft.externalDocID=20808686
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1011-8934&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1011-8934&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1011-8934&client=summon